ORLYNVAH 500 mg/1
sulopenem etzadroxil and probenecid · TABLET, FILM COATED · ITERUM THERAPEUTICS US LIMITED
ORLYNVAH is a tablet, film coated containing sulopenem etzadroxil and probenecid at 500 mg/1, taken oral. Manufactured by ITERUM THERAPEUTICS US LIMITED.
Key Facts
- Brand Name
- ORLYNVAH
- Generic Name
- sulopenem etzadroxil and probenecid
- NDC Code (Product)
81153-100- Manufacturer
- ITERUM THERAPEUTICS US LIMITED
- Strength
- 500 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA213972
- Marketing Start
- 07/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is ORLYNVAH used for?
ORLYNVAH contains sulopenem etzadroxil and probenecid. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is ORLYNVAH a controlled substance?
ORLYNVAH is not classified as a controlled substance by the DEA.
What is the generic name for ORLYNVAH?
The generic name for ORLYNVAH is sulopenem etzadroxil and probenecid. There are no other listed brand versions of sulopenem etzadroxil and probenecid.
What is the NDC code for ORLYNVAH 500 mg/1?
The NDC (National Drug Code) for ORLYNVAH 500 mg/1 is 81153-100, listed by ITERUM THERAPEUTICS US LIMITED.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)